Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 6/2006

01-04-2006 | Current Opinion

Shift in the Epidemiology of Pertussis Infection

An Indication for Pertussis Vaccine Boosters for Adults?

Authors: Dr Sylvia H. Yeh, ChrisAnna M. Mink

Published in: Drugs | Issue 6/2006

Login to get access

Abstract

Pertussis vaccination of young children has been effective in reducing the overall disease burden due to Bordetella pertussis in many countries. However, the disease has not been eliminated, although humans are the only known host of this pathogen. In fact, in some countries, the number of reported cases has increased dramatically from their nadir and epidemics routinely occur. In areas where >80% of children <2 years of age have been vaccinated, the burden of disease has shifted from elementary school-aged children (who are presumably protected by vaccination) to young infants (<6 months of age) and individuals >11 years of age. With the recent availability of acellular pertussis vaccines for older children to adults, consideration of a change in current vaccination policy is necessary in order to provide better disease control.
Footnotes
1
The use of trade names is for product identification purposes only and does not imply endorsement.
 
Literature
1.
Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. 4th ed. Philadelphia (PA): WB Saunders Company, 1998: 1423–40
2.
Laring JS, Hay M. Whooping-cough: its prevalence and mortality in Aberdeen. Public Health 1902; 14: 584–98CrossRef
3.
4.
Brennan M, Strebel P, George H, et al. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis. J Infect Dis 2000; 181: 210–5PubMedCrossRef
5.
Gehanno JF, Pestel-Caron M, Nouvellon M, et al. Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect Control Hosp Epidemiol 1999; 20: 549–52PubMedCrossRef
6.
Centers for Disease Control and Prevention. Pertussis outbreak — Vermont 1996. MMWR 1997; 46: 8226
7.
de Melker HE, Conyn-van Spaendonck MAE, Rumke HC, et al. Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole cell vaccine. Emerg Infect Dis 1997; 3: 175–8PubMedCrossRef
8.
Klement E, Uliel L, Engel I, et al. An outbreak of pertussis among young Israeli soldiers. Epidemiol Infect 2003; 131: 1049–54PubMedCrossRef
9.
van der Zee A, Mooi F, van Enbden J, et al. Molecular evolution and host adaptation of Bordetella spp: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol 1997; 179: 6609–17PubMed
10.
Heininger U, Stehr K, Schmitt-Grohe S, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13: 306–9PubMedCrossRef
11.
Hewlett EL. A commentary on the pathogenesis of pertussis. Clin Infect Dis 1999; 28 Suppl. 2: S94–8PubMedCrossRef
12.
Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005; 5: S10–18
13.
Edwards KM, Decker MD, Mortimer EA. Pertussis vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd ed. Philadelphia (PA): WB Saunders Company, 1999: 293–344
14.
Bass JW, Stephenson SR. The return of pertussis. Pediatr Infect Dis 1978; 6: 141–4
15.
Mertsola J, Ruuskanen O, Eerola E, et al. Intrafamilial spread of pertussis. J Pediatr 1983; 103: 359–63PubMedCrossRef
16.
Cherry JD. The epidemiology of pertussis and pertussis immunization on in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984; 14: 1–78PubMed
17.
Centers for Disease Control and Prevention. Pertussis: United States, January 1992–June 1995. MMWR 1995; 44: 525–9
18.
Centers for Diseases Control and Prevention. Pertussis-United States, 1997–2002. MMWR 2002; 51(04): 73–6
19.
20.
Andrews R, Herceg A, Toberts C. Pertussis notifications in Australia 1991 to 1997. Commun Dis Intell 1997; 21: 145–8PubMed
21.
22.
Murphy T, Bisgard K, Sanden G. Diagnosis and laboratory methods. In: Guidelines for the control of pertussis outbreaks. Atlanta (GA): Centers for Disease Control and Prevention, 2000
23.
Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555–63PubMedCrossRef
24.
Kosters K, Riffelmann M, Wirsing von Konig CH. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J Med Microbiol 2001; 50: 436–40
25.
Riffelmann M, Wirsing von Konig CH, Caro V, et al. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005; 43: 4925–9PubMedCrossRef
26.
Marchant CD, Loughlin AM, Lett SM, et al. Pertussis in Massachusetts, 1981–1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 1994; 169: 1297–305PubMedCrossRef
27.
Baughman AL, Bisgard KM, Edwards KM, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004; 11: 1045–53PubMed
28.
Cattaneo LA, Reed GW, Haase DH, et al. The seroepidemiology of Bordetella pertussis infection: a study of persons ages 1–65. J Infect Dis 1996; 173: 1256–9PubMedCrossRef
29.
Cromer BA, Goydos J, Hackell J, et al. Unrecognized pertussis infections in adolescents. Am J Dis Child 1993; 147: 575–7PubMed
30.
Wright SW, Edwards KM, Decker MD, et al. Pertussis seroprevalence in Emergency Department staff. Ann Emerg Med 1994; 21: 413–7CrossRef
31.
Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275: 1672–4PubMedCrossRef
32.
Yih WK, Lett SM, de Vignes FN, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults 1989–1998. J Infect Dis 2000; 182: 1409–16PubMedCrossRef
33.
Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol 1999; 20: 120–3PubMedCrossRef
34.
Mink CM, Cherry JD, Christ PD, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14: 464–71PubMedCrossRef
35.
Wright SW, Edwards KK, Decker MD, et al. Pertussis infection in adults with persistent cough. JAMA 1995; 273: 1044–6PubMedCrossRef
36.
Rosenthal S, Stebel P, Cassiday P, et al. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis 1995; 171: 1650–2PubMedCrossRef
37.
Jansen DL, Gray GC, Putman SD, et al. Evaluation of pertussis in US Marine corp trainees. Clin Infect Dis 1997; 25: 1099–107PubMedCrossRef
38.
Senzilet LD, Halperin SA, Spika JS, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32: 1691–87PubMedCrossRef
39.
Roberson PW, Goldberg H, Jarvie BH, et al. Bordetella pertussis infection: a cause of persistent cough in adults. Med J Aust 1987; 146: 522–5
40.
Gilberg S, Njamkepo E, Parent du Ch↦elet I, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002; 186: 415–8PubMedCrossRef
41.
Davis J. Clinical and economic effects of pertussis outbreaks. Pediatr Infect Dis J 2005 Jun; 24 (6 Suppl.): S109–16PubMed
42.
43.
44.
Valenti WM, Pincus PH, Messner MK. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 1980; 134: 520–7PubMed
45.
Beiter A, Lewis K, Pineda EF, et al. Unrecognized maternal peripartum pertussis with subsequent fatal neonatal pertussis. Obstet Gynecol 1993; 82: 691–3PubMed
46.
Deen JL, Mink CM, Cherry JD, et al. A household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21: 1211–9PubMedCrossRef
47.
Bisgard KM, Pascaul FB, Ehresmann KR, et al. Infant pertussis, who was the source? Pediatr Infect Dis J 2004; 23: 985–9PubMedCrossRef
48.
Crowcroft NS, Booy R, Harrison T, et al. Severe and unrecognized pertussis in UK infants. Arch Dis Child 2003; 88: 202–6CrossRef
49.
Grimpel E, Baron S, Levy-Bruhl D, et al. Influence of vaccination coverage on pertussis transmission in France. Lancet 1999; 345: 1699–700CrossRef
50.
Schmitt-Grohe S, Cherry JD, Heininger U, et al. Pertussis in German adults. Clin Infect Dis 1995; 21: 860–6PubMedCrossRef
51.
Maclean DW. Adults with pertussis. J R Coll Gen Pract 1982; 32: 298–300PubMed
52.
Aoyama T, Takeuchi Y, Goto A, et al. Pertussis in adults. Am J Dis Child 1992; 146: 163–6PubMed
53.
Edward R, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J 2005; 5: s44–7
54.
Long SS, Welkon CI, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161: 480–6PubMedCrossRef
55.
Halperin SA, Wang EEL, Law B, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991–1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 1999; 28(6): 1238–43PubMedCrossRef
56.
De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182: 174–9PubMedCrossRef
57.
Lee LH, Pichichero ME. Costs of illness due to Bordetella pertussis in families. Arch Fam Med 2000; 9: 989–96PubMedCrossRef
58.
Purdy KW, Hay JW, Botteman MF, et al. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin Infect Dis 2004; 39: 20–8PubMedCrossRef
59.
Calugar A, Ortega-Sanchez I, Tiwari T, et al. Nosocomial pertussis: cost of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006; 42: 981–8PubMedCrossRef
60.
61.
62.
Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulation of five new strategies. Vaccine 2004; 22: 3154–65PubMedCrossRef
63.
Lee GM, LeBaron C, Murphy TV, et al. Pertussis in adolescents and adults: should we vaccinate? Pediatrics 2005; 115: 1675–84PubMedCrossRef
64.
Iskedjian M, Walker JH, Hemels ME. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada. Vaccine 2004; 22: 4215–27PubMedCrossRef
65.
Scuffham PA, McIntyre PB. Pertussis vaccination strategies for neonates: an exploratory cost-effectiveness analysis. Vaccine 2004; 22: 2953–64PubMedCrossRef
66.
Hethcote HW, Horby P, Mclntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004; 22: 2181–91PubMedCrossRef
Metadata
Title
Shift in the Epidemiology of Pertussis Infection
An Indication for Pertussis Vaccine Boosters for Adults?
Authors
Dr Sylvia H. Yeh
ChrisAnna M. Mink
Publication date
01-04-2006
Publisher
Springer International Publishing
Published in
Drugs / Issue 6/2006
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200666060-00001

Other articles of this Issue 6/2006

Drugs 6/2006 Go to the issue

Adis Drug Evaluation

Pentosan Polysulfate

Adis Drug Profile

Gadofosveset

Adis Drug Profile

Sumatriptan Fast-Disintegrating/Rapid-Release Tablets

Leading Article

Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1

Adis Drug Profile

Lubiprostone

Therapy in Practice

Gram-Positive Cocci Infections in Intensive Care